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a b s t r a c t 
The ﬂavoprotein monooxygenase (FPMO) from Stenotrophomonas maltophilia (SMFMO, Uniprot:
B2FLR2) catalyses the asymmetric oxidation of thioethers and is unusual amongst FPMOs in its ability to
use the non-phosphorylated cofactor NADH, as well as NADPH, for the reduction of the FAD coenzyme. In
order to explore the basis for cofactor promiscuity, structure-guided mutation of two residues in the co-
factor binding site, Gln193 and His194, in SMFMO were performed in an attempt to imitate the cofactor
binding site of the NADPH-dependent FMO from Methylophaga aminisulﬁdivorans sp. SK1 (mFMO), in
which structurally homologous residues Arg234 and Thr235 bind the NADPH 2 ′ -ribose phosphate. Mu-
tation of His194 to threonine proved most signiﬁcant, with a switch in speciﬁcity from NADH to NADPH
[( k cat / K m NADH) / k cat / K m NADPH) from 1.5:1 to 1:3.5, mostly as a result of a reduced K m for NADPH of
approximately sevenfold in the His194Thr mutant. The structure of the Gln193Arg / His194Thr mutant
revealed no substantial changes in the backbone of the enzyme or orientation of side chains resulting
from mutation. Mutation of Phe52, in the vicinity of FAD, and which in mFMO is an asparagine thought to
be responsible for ﬂavin hydroperoxide stabilisation, is, in SMFMO, a determinant of enantioselectivity
in sulfoxidation. Mutation of Phe52 to valine resulted in a mutant that transformed para -tolyl methyl
sulﬁde into the ( S )-sulfoxide with 32% e.e., compared to 25% ( R )- for the wild type. These results shed
further light both on the cofactor speciﬁcity of FPMOs, and their determinants of enantioselectivity,
with a view to informing engineering studies of FPMOs in the future. 
C © 2013 The Authors. Published by Elsevier B.V. on behalf of Federation of European Biochemical
Societies. Open access under CC BY-NC-ND license. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1. Introduction 
Flavoprotein monooxygenases [ 1 ] are a class of oxidative enzymes
which, in addition to having important roles in metabolism in eu-
karyotes [ 2 ] and in the production of secondary metabolites in lower
organisms [ 3 , 4 ], have potential for applications in asymmetric or-
ganic synthesis. This is due to the ability of different subgroups of
these enzymes (‘A ’ –‘F ’ [ 1 ]) to catalyse useful oxygenation reactions
such as hydroxylation and Baeyer–Villiger (BV) oxidation. FPMOs of
Class ‘B ’ , which include Baeyer–Villiger monooxygenases (BVMOs), N-
hydroxylating monooxygenases and ﬂavin monooxygenases (FMOs),
also catalyse the asymmetric oxidation of heteroatom-containingAbbreviations: SMFMO, Stenotrophomonas maltophilia ﬂavin monoxygenase; 
mFMO, ﬂavin monooxygenase from Methylophaga aminisulﬁdivorans ; PAMO, pheny- 
lacetone monooxygenase; CHMO, cyclohexanone monooxygenase. 
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http://dx.doi.org/10.1016/j.fob.2013.09.008 compounds ( Fig. 1 ) such as prochiral thioethers [ 5 ]. Class B FPMOs
most often exist in the form of a single polypeptide that employs the
nicotinamide cofactor NADPH to reduce bound ﬂavin (FAD), forming
FADH 2 , which reacts with molecular oxygen to form the oxidising
species, a (hydro)peroxy ﬂavin intermediate [ 1 ], which then under-
goes a nucleophilic attack by the sulphur atom of the thioether. The
majority of these enzymes have been shown to be dependent on the
phosphorylated nicotinamide cofactor NADPH as the hydride donor
in the ﬂavin reduction step. There are also NADH-dependent ﬂavo-
protein monooxygenases, but in these cases, the reduction of ﬂavin
(in that case FMN) and the oxygenation of substrate are accomplished
by different enzymes, an NADH oxidase and an oxygenating subunit
respectively. (Class ‘C ’ ﬂavoprotein monooxygenases [ 1 ].) Because of
the lower cost of the non-phosphorylated cofactor NADH, there have
been several attempts to re-engineer nicotinamide cofactor speci-
ﬁcity in, for example, the Baeyer–Villiger monooxygenase group of
FPMOs from NADPH to NADH [ 6 , 7 ], as such a change may provide an
advantage in the commercial application of FPMOs. 
In previous work [ 8 ], we reported the cloning and expression of
a gene from the marine bacterium Stenotrophomonas maltophilia that
encoded a Class B FPMO, a ﬂavin monooxygenase named SMFMO,ean Biochemical Societies. Open access under CC BY-NC-ND license.
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Table 1 
Kinetics of nicotinamide cofactor oxidation by SMFMO and mutants of Gln193 and His194. 
SMFMO variant K m (NADH M x 10 
−6 ) k cat (NADH s −1 ) 
k cat / K m (NADH s 
−1 
M −1 ) 
K m (NADPH M x 
10 −6 ) k cat (NADPH s −1 ) 
k cat / K m (NADPH s 
−1 
M −1 ) 
Wild-type 23.7 ± 9.1 0.029 ± 0.003 1223 27.3 ± 5.3 0.022 ± 0.002 805 
Gln193Arg 21.2 ± 4.3 0.031 ± 0.003 1476 8.3 ± 1.6 0.007 ± 0.0005 875 
His194Thr 14.1 ± 2.9 0.012 ± 0.0008 857 4.2 ± 0.7 0.012 ± 0.0004 3000 
Gln193Arg / 
His194Thr 
12.8 ± 6.9 0.010 ± 0.002 769 4.1 ± 2.8 0.003 ± 0.0003 743 
Fig. 1. Asymmetric sulfoxidation reactions catalysed by ﬂavoprotein monooxygenases 
(FPMOs). NAD(P)H is used to reduce the ﬂavin prior to reaction with molecular oxygen, 
yielding (hydroperoxy)ﬂavin intermediate, which is the oxidant in the reaction. 
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Fig. 2. Superimpositionof nicotinamide cofactor binding site in ﬂavoprotein monooxy- 
genase mFMO from Methylophaga aminisulﬁdivorans ( 2XLP , grey) and SMFMO (white), 
showing residues Gln193 and His194 in SMFMO targeted for mutation. The SMFMO 
structure was determined in the presence of sulfate ions, which bind in the phosphate 
site(s). hich was unusual in its ability to preferentially employ NADH 
s the nicotinamide cofactor for ﬂavin reduction. SMFMO therefore 
atalysed the NADH-dependent asymmetric oxidation of prochiral 
hioethers and also the regioselective Baeyer–Villiger oxidation of the 
odel Baeyer–Villiger monooxygenase substrate bicyclo[ 3 . 2 .0]hept- 
-en-6-one, the latter albeit with poor enantioselectivity. Recently, a 
ore extended group of FMOs related to SMFMO, which also accepts 
ither NADH or NADPH as cofactor, has been described encoded in 
he genome of Rhodococcus jostii RHA1 [ 9 ]. In the interests of inves- 
igating the molecular basis of cofactor dependence, the structure of 
MFMO was also determined [ 8 ] and compared with the structure 
f a known NADPH-dependent FMO, called mFMO, from the methy- 
otrophic bacterium Methylophaga aminisulﬁdivorans strain SK1 [ 10 ]. 
FMO has recently been employed for the asymmetric oxidation of a 
eries of prochiral sulﬁdes to give predominantly ( S )-sulfoxide prod- 
cts with moderate to good enantiomeric excess [ 11 ]. In structural 
tudies by two groups [ 12 , 13 ], the molecular determinants govern- 
ng the binding of the 2 ′ ribose phosphate of NADPH in mFMO, and 
hich discriminates between NADPH and NADH, have been revealed 
PDB: 2XLP , PDB: 2XVJ and related structures). The comparison of the 
tructures of SMFMO and mFMO [ 6 ] provided leads for further inves- 
igation of the cofactor preference observed in SMFMO, and suggested 
venues for the potential alteration of cofactor speciﬁcity in FPMOs 
s a whole. 
In this paper we report the results of investigations designed to 
robe the determinants of cofactor promiscuity in SMFMO, and also 
utagenesis of the active site immediately surrounding the ﬂavin 
oenzyme, which has revealed a residue, Phe52, having inﬂuence over 
he enantioselectivity of sulfoxidation by this enzyme. 
. Results and discussion 
.1. Mutations affecting cofactor speciﬁcity in SMFMO 
The structure of SMFMO was determined to be a dimer, with a 
onomer fold similar to that of mFMO, and featured one molecule 
he coenzyme FAD in each subunit [ 8 ]. Although NAD(P)H was not 
bserved in the active site, the growth of the crystals in high con- 
entrations of lithium sulfate resulted in sulfate ions being bound to 
AD(P)H phosphate binding sites of SMFMO, as identiﬁed by super- 
mposition of the structure with the mFMO–NADPH complex [ 8 ]. This 
uperimposition revealed that the relaxation in nicotinamide cofactor 
peciﬁcity in this enzyme might be attributed to the substitution of two residues found in NADPH-dependent mFMO: Arg234 and Thr235 
(observed to bind the 2 ′ phosphate on the NADPH ribose in that en- 
zyme) for a glutamine (Gln193) and histidine (His194) in SMFMO 
( Fig. 2 ). In order to explore the determinants of cofactor promiscuity 
in SMFMO, we therefore constructed mutants Gln193Arg, His194Thr 
and the double mutant Gln193Arg / His194Thr, each of which was 
expressed in the soluble fraction of cells of Escherichia coli to approx- 
imately the same extent as the wild-type enzyme. The oxidation of 
NADPH and NADH by each variant was measured and compared to 
the wild-type ( Table 1 ). 
Mutation of Gln193 to arginine appears to have resulted in a 
mutant with a fourfold reduced K m for NADPH, although turnover 
was compromised, resulting in a mutant of comparable catalytic efﬁ- 
ciency ( k cat / K m ) to the wild-type with NADPH. Binding and turnover 
of NADH was not greatly affected in this mutant, compared to wild- 
type activity. Mutation of His194 to threonine on the other hand, 
resulted in an enzyme of approximately threefold increased catalytic 
efﬁciency with NADPH owing largely to a sevenfold decrease in the 
K m for NADPH. Binding of NADH was also slightly improved, although 
with a drop in turnover rates. A combination of these effects was ob- 
served with the double mutant Gln193Arg / His194Thr,in which the 
lower K m and lower k cat of the Gln193Arg and His194Thr mutants 
respectively combined to give a mutant of lower catalytic efﬁciency 
overall. Thus, the His194Thr mutation resulted in reduced catalytic 
efﬁciency with NADH and increased efﬁciency with NADPH, mostly 
through a signiﬁcantly reduced K m , and an overall change in ratio 
of ( k cat / K m NADH) / k cat / K m NADPH) from 1.5:1 to 1:3.5. The greater 
contribution of the threonine residue to NADPH binding is perhaps 
reﬂected in the bond distances from the threonine 235 side chain to 
the ribose 2 ′ phosphate oxygen in mFMO structures such as 2XLP : 
this is 2.6 A˚ compared to 3.2–3.5 A˚ for the arginine 234 side-chain 
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Fig. 3. Superimposition of nicotinamide cofactor binding site in wild-type SMFMO 
(WT, white) and Gln193Arg / His194Thr double mutant (DM, grey). The r.m.s.d. between 
the wild-type structure and double mutant structure over 330 C-alpha atoms was 0.42 
A˚. 
Table 2 
Enantioselectivity of selected SMFMO mutants towards the substrates methyl- p -tolyl 
sulﬁde and ethyl phenyl sulphide. 
Variant 
Absolute conﬁguration and enantiomeric excess of 
sulfoxide product 
Methyl- p -tolyl 
sulfoxide product of 
biotransformation of 
methyl- p -tolyl sulﬁde 
Ethyl phenyl sulfoxide 
product of 
biotransformation of ethyl 
phenyl sulﬁde 
Wild-type ( R )-, 25% e.e. ( R )-, 71% e.e. 
Asn173Ser ( S )-, 12% e.e. n.d. 
Ser174Cys ( R )-, 37% e.e. ( R )-, 48% e.e. 
Phe52Val ( S )-, 32% e.e. Racemic 
Phe52Arg ( R )-, 38% e.e. n.d. 
Phe52Leu ( R )-, 24% e.e. ( R )-, 67% e.e. 
n.d. = not determined. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 nitrogen atoms with relevant phosphate oxygens. 
In order to exclude the possibility that substitution of Gln193 and
His194 for the residues arginine and threonine had caused major
structural changes in the cofactor binding site, we determined the
crystal structure of the Gln193Arg / His194Thr mutant of SMFMO at
2.60 A˚ resolution. In contrast to the wild-type structure, which fea-
tured two molecules in the asymmetric unit arranged as a dimer, the
double mutant structure solution revealed eight monomers, with four
dimers. Omit maps after reﬁnement in the absence of ﬂavin clearly
revealed residual density for the FAD at the active site of each subunit.
In common with the wild-type structure, there was no density corre-
sponding to a stretch of residues in the region of Glu210 to Asp234,
and these areas could not be modeled. Each subunit was otherwise
largely complete, although subunit ‘A ’ featured the poorest density
for side-chains and had average B-factors of 71 versus an average
value of 50 for the assembly overall. Subunits ‘A ’ from the wild-type
structure and subunit ‘H ’ (which had the lowest ‘B ’ -factors of 40)
from the Gln193Arg / His194Thr mutant structure were superposed
in order to examine whether the introduction of the new residues
was likely to have distorted the cofactor 2 ′ phosphate binding region
in the enzyme. An overlap of the cofactor binding region of these
subunits from the wild-type and double-mutant structures ( Fig. 3 )
actually revealed very little movement of the backbone and the posi-
tion of the sulfate ion (which overlays with the NADPH 2 ′ phosphate
from NADPH complex structures of mFMO), is also conserved from
wild-type to double mutant enzyme. 
Analysis of SMFMO variants with phosphate binding site mu-
tations demonstrates that, while the strength of NADPH binding can,
in part, be determined by the identity of the residue at position 194
and also 193, a straight swap of residue(s) for those found in NADPH-
dependent FMOs does not engineer absolute NADPH speciﬁcity in the
cofactor-promiscuous enzyme. This may simply be a steric effect, asresidual space is still available in the cofactor binding site to accom-
modate the smaller NADH ribose 2 ′ hydroxyl. In NADPH-dependent
mFMO, this residual space is also available so it remains difﬁcult to
conclude how NADH binding might be disfavoured in that enzyme.
The activity of mFMO with NADH has not, to our knowledge, been
reported however, so it is possible that some activity with NADH ex-
ists. However, the Arg / Thr couple in the cofactor phosphate binding
pocket of mFMO is conserved amongst other NADPH- speciﬁc ﬂavopro-
tein monooxygenases such as the BVMOs phenylacetone monooxy-
genase [ 14 ] and cyclohexanone monooxygenase from Rhodococcus
[ 15 ]. In a study of nicotinamide cofactor binding in PAMO, Fraaije and
co-workers determined that the relevant arginine 217 was essential
for NADPH binding, but that the mutation of the adjacent threonine
(218) did not have a signiﬁcant effect in that instance [ 7 ]. Interest-
ingly, substitution of a histidine residue at position 220 in PAMO for
a glutamine, increased the catalytic efﬁciency of the enzyme with
NADH threefold, however, the new glutamine is not structurally ho-
mologous with Gln193 in SMFMO. Although mutation of Gln193 in
our study did not radically affect cofactor speciﬁcity in SMFMO, there
is extensive precedent for glutamine as a facilitating determinant of
cofactor promiscuity in, for example, formate dehydrogenases (FDHs).
Most FDHs are NAD + dependent, yet both mutational studies [ 16 ]
and genomic screens [ 17 ] have revealed enzymes of either promiscu-
ous cofactor recognition ability or of strict NADPH dependence. The
structural basis for this change is partly the exchange of a glutamate
or aspartate residue in NADH-dependent enzymes, which repel neg-
atively charged phosphate, for a glutamine, which is neutral. In an ef-
fort, therefore, to engineer strict NADH-speciﬁcity in SMFMO, Gln193
was mutated to Glu, but unfortunately this resulted in a mutant that
was not expressed in the soluble fraction of the E. coli cells used for the
study. Further structural and mechanistic studies of SMFMO and the
larger group of cofactor-promiscuous FMOs identiﬁed by Riebel and
co-workers [ 9 ] may help to shed further light on cofactor speciﬁcity
in this group of FPMOs. 
2.2. Mutations affecting enantioselectivity of sulfoxidation in SMFMO 
Mutations in and around the active site of Baeyer–Villiger
monooxygenases and ﬂavin-dependent monooxygenases such as
mFMO have revealed amino acid residues that have effects on both
the activity and selectivity of the enzymes [ 18 , 19 ]. The structure of
SMFMO revealed the environment surrounding the ﬂavin, and al-
lowed for a structure-informed approach to the analysis of the active
site, with a view to either improving or altering the enantioselectivity
of the enzyme. In order to identify residues with possible direct effects
on ligand binding, the active site was superimposed with the structure
of mFMO that had been determined in complex with the substrate in-
dole ([ 13 ]; PDB: 2XVJ ; Fig. 4 ). On this basis, Phe52, Asn173 and Ser174
were selected as the ﬁrst residues for mutation, as being close to the
indole ligand and also the C4 position of the ﬂavin which is the site
of formation of the (hydro)peroxy ﬂavin intermediate. The mutants
were tested for their ability to oxidise the substrates methyl- p -tolyl
sulﬁde and ethyl phenyl sulﬁde and also for their enantioselectivity
towards those substrates ( Table 2 ). 
Mutation of asparagine 173 resulted largely in variants of low ac-
tivity, although soluble expression was comparable to that obtained
with the wild-type SMFMO. Mutation of Serine 174 resulted again
in inactive mutants except where the mutation was conservative, to
cysteine. Although neither interacts directly with ﬂavin, superimpo-
sition of the mFMO structure in complex with NADPH suggests that
residues 173 and 174 may be in proximity to the nicotinamide ring
of the cofactor; indeed position 173 is occupied by tyrosine 212 in
mFMO, in which it is thought to act as a ‘backdoor ’ residue, protect-
ing the reactive site from bulk solvent [ 20 ]. 
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Table 3 
Biotransformation of sulﬁdes by Phe52Val mutant of SMFMO compared to biotransformations of equivalent substrates using the wild-type enzyme. 
Substrate Absolute conﬁguration and enantiomeric excess of sulfoxide product 
WT SMFMO Phe52Val mutant 
( R )-, 25% e.e. ( S )-, 32% e.e. 
( R )-, 71% e.e. ( S )-, 11% e.e. 
( R )-, 24% e.e. ( S )-, 7% e.e. 
( R )-, 21% e.e. ( S )-, 8% e.e. 
( S )-, 19% e.e. ( S )-, 19% e.e. 
( R )-, 30% e.e. ( S )-, 41% e.e. 
( R )-, 80% e.e. ( R )-, 28% e.e. 
Table 4 
PCR oligonucleotide primers used in this study. 
Mutant Forward primer Reverse primer 
Q193R GAAACGACTTGGATCACACGTCACGAGCCGGCCTTTCTGGC GCCAGAAAGGCCGGCTCGTGACGTGTGATCCAAGTCGTTTC 
H194T GACTTGGATCACACAGACCGAGCCGGCCTTTCTGG CCAGAAAGGCCGGCTCGGTCTGTGTGATCCAAGTC 
N173X GCAATTATCGGTGGCGGTNDTTCTGGCGCACAG n / a 
S174X CGGTGGCGGTAATNDTGGCGCACAGATCCTGGC n / a 
F52X GGCATTCTCTGCATCTGNDTAGCCCAGCGGGCTGG n / a 
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tPhe52 mutants proved to be more active, with mutation to hy- 
rophobic leucine giving a mutant which was also moderately enan- 
ioselective with the chosen substrates. However, the Phe52 mutant 
ith a smaller hydrophobic group, valine, gave an oxidised product of 
nverted absolute conﬁguration compared to the wild-type enzyme. 
n an effort to augment this effect, Phe52 was also mutated to smaller 
lanine, but in this case, the mutant was not expressed well, and cell 
xtracts that contained it did not appear yellow, suggesting that a 
ide-chain of minimum size is required in this position to maintain 
avin binding. Using the Phe52Val mutant therefore, the inversion 
f enantioselectivity was explored with other thioether substrates 
 Table 3 ). Whilst enantioselectivity was poor in most cases, the ab- 
olute conﬁguration of products was opposite to that obtained with 
he wild-type enzyme save for the p -chloro thioanisole, in which the ( R )-selectivity was maintained, although substantially reduced. 
The role of Phe52 in SMFMO appears to be different to that served 
by structurally homologous residues in other FPMOs. In mFMO, the 
position is occupied by asparagine [ 11 ]. Mutation of this residue, even 
conservatively to serine, resulted in an inactive enzyme [ 20 ]. It has 
been suggested that Asn73 is involved in stabilisation of the ﬂavin 
hydroperoxide in mFMO, as its mutation results in an enzyme that 
is unable to oxygenate exogenous substrates [ 20 ]. However, in other 
FPMOs, the mutation of residues in this position has had little or 
no effect on enzyme activity [ 21 ]. In SMFMO, the residue appears 
to have a role in substrate binding, as the substitution of a smaller 
residue, valine, has resulted in mutants of altered enantioselectiv- 
ity. The enantioselectivity of FPMOs with respect to sulfoxidation has 
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Fig. 4. Superimposition of ﬂavin-binding site of SMFMO (carbon atoms in white) with 
ﬂavin-binding site of mFMO (carbon atoms in grey) in complex with the substrate 
indole (taken from PDB: 2XVJ ; [ 13 ]) and illustrating sites chosen for mutation in SMFMO 
in order to investigate enantioselectivity in SMFMO. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 successfully been altered previously through mutation at, for exam-
ple, Met446 in the active site in PAMO, for which structure-guided
mutation resulted in a variant, Met446Gly, which catalysed the oxi-
dation of methyl p- tolyl sulﬁde to its ( R )-sulfoxide enantiomer with
92% e.e. compared to 6% for the wild-type [ 19 ]. In the absence of a
structure, Reetz and co-workers used directed evolution to create mu-
tants of cyclohexanone monooxygenase (CHMO) from Acinetobacter
calcoaceticus , which were enantiocomplementary in respect of the ox-
idation of methyl p -methyl benzyl thioether, with mutant Phe432Ser
giving the ( R )-sulfoxide enantiomer with 98.7% e.e. and the Phe16Leu /
Phe277Ser variant giving the ( S )-product with 95.2% e.e. [ 18 ]. At this
point it is interesting to note that a number of different sites in FPMOs
have proved to be valuable in respect of mutation for altered or im-
proved enantioselectivity, including sites both proximal and remote
from the ﬂavin binding site. 
FPMOs continue to be an interesting group of enzymes in respect
of their potential application in industrial biotechnology. In order to
realise this potential, applications of the enzymes will beneﬁt from
both structure-guided and random mutagenesis studies that may help
to expand their substrate repertoire, or provide catalysts of altered or
improved selectivity. Amongst the FPMOs, SMFMO is, despite its poor
enantioselectivity, interesting as it is one of the only enzymes, along
with the BVMO mekA [ 22 ] and the recently identiﬁed group of en-
zymes from Rhodococcus sp. RHA1 [ 17 ] to demonstrate acceptance of
the cheaper nicotinamide cofactor NADH. The studies reported herein
identify His194 in particular as a determinant of cofactor promiscu-
ity in SMFMO and suggest avenues for engineering of other FPMOs
for NADH acceptance. In addition, the mutation of Phe52 in SMFMO
has revealed not an absolute requirement for this residue but rather
an interesting effect on the active site recognition of sulﬁde sub-
strates, such that enantioselectivity is altered by its substitution with
an amino acid side-chain of smaller size. The nature and role of this
residue in SMFMO and structurally homologous residues in other FP-
MOs is therefore very much still under scrutiny. 
3. Materials and methods 
3.1. Generation of mutant SMFMO genes and puriﬁcation of SMFMO 
variants 
The gene encoding wild-type SMFMO (B2FLR2) was the same as
that described previously [ 8 ]. Point mutations in the gene were gen-
erated using site-directed mutagenesis employing either mutation
speciﬁc primers or an NDT codon-based approach for the generation
of restricted libraries at certain positions, as described by Reetz and
co-workers [ 23 ]. A full list of primers for mutagenic PCR can be foundin Table 4 . Following PCR, reaction mixtures were subjected to di-
gest with the enzyme DpnI, after which the mixtures were used to
transform cells of E. coli Novablue singles TM (Merck-Millipore, USA).
Plasmids recovered using standard miniprep techniques from colony
transformants were subjected to DNA sequencing to conﬁrm the in-
corporation of the desired mutations. Using the mutant plasmids, the
SMFMO muteins were expressed using techniques established for
WT-SMFMO [ 8 ] ( Table 4 ). 
Table 5 
Data collection and reﬁnement statistics for Q193R / H194T double mutant of SMFMO
(ﬁgures in brackets correspond to data corresponding to the highest resolution shell). 
Q193R / H194T double mutant of SMFMO
Beamline Diamond I03 
Wavelength ( ˚A) 0.97630 
Resolution ( ˚A) 59.78–2.60 (2.65–2.60) 
Space group P 3 2 
Unit cell ( ˚A) a = 170.54; b = 170.54; c = 101.80 
α = β = 90.00; γ = 120 
No. of molecules in the asymmetric 
unit 
8 
Unique reﬂections 102,301 (6014) 
Completeness ( %) 97.8 (99.4) 
R merge ( %) 0.15 (0.56) 
R p.i.m. 0.12 (0.44) 
Multiplicity 4.8 (4.6) 
〈 I /σ (I) 〉 4.6 (2.1) 
CC 1 / 2 0.99 (0.71) 
Overall B factor from Wilson plot 
( ˚A 2 ) 
43 
R cryst / R free ( %) 25.5 / 29.5 
r.m.s.d 1–2 bonds ( ˚A) 0.011 
r.m.s.d 1–3 angles ( o ) 1.675 
Avge main chain B ( ˚A 2 ) 50 
Avge side chain B ( ˚A 2 ) 51 
Avge water B ( ˚A 2 ) 34 
3.2. Enzyme assays and biotransformations 
Steady-state kinetic constants for the NADH and NADPH oxida-
tion by SMFMO and its variants were determined using the method
employed for hydroxyacetophenone monooxygenase (HAPMO, [ 6 ])
and employed previously for SMFMO [ 8 ]. Biotransformations using
cell lysates with cofactor recycling were performed using the method
of Faber and co-workers [ 24 ] and as used for WT-SMFMO previously
[ 8 ]. Standard GC and chiral GC analysis of the biotransformation of
thioether substrates used in this study was performed as for the WT-
SMFMO [ 8 ]. 
3.3. Crystallisation of SMFMO Gln193Arg / His194Thr double mutant 
The SMFMO Gln193Arg / His194Thr double mutant was crys-
tallised in conditions similar to that used for the wild-type struc-
ture [ 8 ]. The crystals used for diffraction experiments were ob-
tained from hanging crystal drops set up in 24-well plate crystalli-
sation dishes. The reservoir contained 0.9 M lithium sulphate in
100 mM bis–tris propane buffer (pH 5.6). The protein concentra-
tion used was 3 mg mL −1 . Crystals were tested for diffraction using
a Rigaku Micromax-007HF ﬁtted with Osmic multilayer optics and
a MARRESEARCH MAR345 imaging plate detector. The crystals that
diffracted to a resolution of greater than 3 A˚ were ﬂash-cooled in liq-
uid nitrogen in a cryogenic solution containing the mother liquor that
also contained 10% (v / v) glycerol. 
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R.4. Data collection, structure solution, model building and reﬁnement 
f SMFMO Gln193Arg / His194Thr double mutant 
A complete dataset was collected on beamline I03 at the Diamond 
ight Source, Oxfordshire, UK. The data were processed and integrated 
sing XDS [ 25 ] and scaled using SCALA [ 26 ] as included within the 
ia2 processing system [ 27 ]. The data collection statistics are given 
n Table 5 . The crystals were in space group P 3 2 . The structure was 
olved using the program MOLREP [ 28 ] using a monomer of the WT 
MFMO structure (PDB: 4a9w ) as the model. The solution on this 
ccasion contained eight monomers (A–H) in the asymmetric unit, 
hich constituted four dimers in the ﬁnal model. The structure was 
mproved using iterative rounds of building in Coot [ 29 ] and reﬁne- 
ent using REFMAC [ 30 ]. In reﬁnement, non-crystallographic sym- 
etry (NCS) restraints were applied for chains B–H against chain A. 
ollowing building of the protein and the water molecules, the ﬂavin 
oenzyme FAD was modelled into residual density in the omit maps 
n each of the eight subunits. The ﬁnal structure had R cryst and R free 
alues of 25.5% and 29.5% respectively and was ﬁnally validated using 
ROCHECK [ 31 ]. The Ramachandran plot showed 96% of residues to 
e situated in the most favoured regions, 3.7% in additional allowed 
nd only tyrosine residue Tyr139 in each subunit exhibiting unusual 
ackbone conformations. The coordinates and structure factors have 
een deposited in the Protein Databank with the accession code PBD: 
c5o . 
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